Orexo AB (publ) (STO:ORX)
Sweden · Delayed Price · Currency is SEK 15.14
-0.26 (-1.69%)
Sep 4, 2026, 5:29 PM CET
Orexo AB Revenue
Orexo AB had revenue of 5.00M SEK in the quarter ending March 31, 2026, a decrease of -62.12%. This brings the company's revenue in the last twelve months to 122.00M, down -59.16% year-over-year. In the year 2025, Orexo AB had annual revenue of 26.00M, down -12.46%.
Revenue (ttm)
122.00M
Revenue Growth
-59.16%
P/S Ratio
31.85
Revenue / Employee
272.13K
Employees
61
Market Cap
528.71M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.00M | -3.70M | -12.46% |
| Dec 31, 2024 | 29.70M | -609.10M | -95.35% |
| Dec 31, 2023 | 638.80M | 14.50M | 2.32% |
| Dec 31, 2022 | 624.30M | 59.30M | 10.50% |
| Dec 31, 2021 | 565.00M | -98.60M | -14.86% |
| Dec 31, 2020 | 663.60M | -181.20M | -21.45% |
| Dec 31, 2019 | 844.80M | 61.70M | 7.88% |
| Dec 31, 2018 | 783.10M | 139.40M | 21.66% |
| Dec 31, 2017 | 643.70M | -62.20M | -8.81% |
| Dec 31, 2016 | 705.90M | 59.70M | 9.24% |
| Dec 31, 2015 | 646.20M | 75.88M | 13.31% |
| Dec 31, 2014 | 570.32M | 140.96M | 32.83% |
| Dec 31, 2013 | 429.36M | 103.08M | 31.59% |
| Dec 31, 2012 | 326.28M | 126.66M | 63.45% |
| Dec 31, 2011 | 199.61M | -10.89M | -5.17% |
| Dec 31, 2010 | 210.50M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| EQL Pharma AB | 432.35M |
| Enzymatica AB | 51.93M |
| Cinclus Pharma Holding AB | 35.18M |
| Newbury Pharmaceuticals AB | 35.02M |
| Nanexa AB | 33.86M |
| Moberg Pharma AB | 16.76M |
| Enorama Pharma AB | 3.26M |
| Dicot Pharma AB | 200.00K |
Orexo AB News
- 3 days ago - Orexo Reaches Agreement In Principle With DOJ To Resolve Investigation; Stock Up - Nasdaq
- 4 days ago - Orexo AB Transcript: DNB Carnegie Micro Cap Day Conference - Transcripts
- 7 weeks ago - Orexo AB Earnings Call Transcript: Q2 2026 - Transcripts
- 7 weeks ago - Orexo AB Quarterly report: Q2 2026 - Filings
- 7 weeks ago - Orexo AB Slides: Q2 2026 - Filings
- 3 months ago - Orexo AB Slides: ABGSC Investor Days - Filings
- 4 months ago - Orexo AB Earnings Call Transcript: Q1 2026 - Transcripts
- 4 months ago - Orexo AB Quarterly report: Q1 2026 - Filings